In normal breast, CAV1 was expressed in myoepithelial
cells, endothelial cells, and a subset of fibroblasts. Luminal
epithelial cells showed negligible staining. CAV1 was expressed
in 90% of 39 metaplastic breast carcinomas and in 9.4% of 245
invasive breast cancers. In the later cohort, CAV1 expression
was significantly associated with ‘basal-like’ immunophenotype
and with shorter disease-free and overall survival on univariate
analysis.
CAV1 gene amplification was found in 13% of cases
with strong CAV1 expression.
Conclusions: The concurrent CAV1 amplification and overexpression call into question its tumor-suppressive effects in basal-like breast carcinomas.